Ranitidine Distribution Stops In Canada As Regulators Assess Contamination Threat

Health Canada asks ranitidine H2 blocker firms to halt sales until it gathers more information on NDMA contamination, which may form due to the drug’s instability. At least one marketer, Sandoz, also is recalling its ranitidine products in both Canada and US.

Canada_Map

Canadian drug firms have stopped distributing ranitidine antacid products due to contamination with a probable carcinogen while the author of a citizen petition to the the US Food and Drug Administration argues to withdraw the ingredient globally.

In a 17 September statement, Health Canada said it took the “interim, precautionary measure” of asking companies not to distribute...

More from Europe

More from Geography